| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3849716 | American Journal of Kidney Diseases | 2009 | 5 Pages |
Abstract
Corticosteroids and/or cyclosporine constitute the present therapeutic approach for patients with focal segmental glomerulosclerosis (FSGS). The high incidence of side effects for the former and risk of nephrotoxicity combined with the high relapse rate after discontinuation for the latter render their use problematic. Results concerning the role of rapamycin in the treatment of patients with FSGS are conflicting. We describe results for 3 patients treated with a combination of low-dose steroids and rapamycin for FSGS, focusing on the importance of maintaining low drug (rapamycin) levels by using a twice-daily regimen.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
George MD, Erasmia MD, Athanasios PhD, Lydia MD, PhD, Antonios MD,